Bordeaux, France / August 30th, 2022 – TreeFrog Therapeutics, a biotechnology company aimed at making safer, more efficient and more affordable cell therapies based on induced pluripotent stem cells (iPSCs), today announced the nomination of 10 international scientists for the Stem Cell SpaceShot grant. Each nominee was anonymously selected based on a 1-page research project description. In early October, the 10 nominees will be interviewed by an international jury of experts in stem cell biology, gene editing and biophysics, which will determine the winner of the $100,000 Stem Cell SpaceShot Grant. [Read more…]
Ageless Biotech Signs Agreement with Simon Med Imaging of Scottsdale, AZ, One of the Nation’s Largest Siemens 3 Tesla MRI 3D Scan Outpatient Providers, to Advance Its FDA Approved IND Trial
SHERIDAN, Wyo., Aug. 23, 2022 — Ageless Biotech (ABT), Inc., a biotech company created to bring Stem Cell-based Therapeutics to market, is excited to have Simon Med Imaging, one of the major players within the healthcare and biotech research fields, helping to advance its U.S. Food and Drug Administration (FDA) Investigational New Drug Application (IND) for the treatment of Osteoarthritis of the Knee. [Read more…]
GIOSTAR is Conducting Research on Stem Cell Therapy, Which May Help Patients with Osteoarthritis in the Knee
Osteoarthritis in the Knee is the Most Common Form of Arthritis, and Studies Show It Can Be Combated Using Regenerative Techniques
CHICAGO, ILLINIOIS, USA, August 17, 2022 — Global Institute of Stem Cell Therapy and Research (GIOSTAR), a world leader in stem cell research, is led by pre-eminent scientists including Co-Founder and Chief Scientific Officer Dr. Anand Srivastava. Winner of the 2020 Outstanding Achievement Award presented by the Society of American Asian Scientists in Cancer Research (SAASCR), Dr. Srivastava has led the GIOSTAR team in carrying out groundbreaking research on stem cell therapy and other regenerative techniques. This valuable research is being used to help patients combat a vast array of diseases, such as cancer, COVID-19, and osteoarthritis in the knees. [Read more…]
OrganaBio Initiates GMP Manufacturing Operations at its New Cell Therapy Manufacturing Facility
-
With the commencement of GMP manufacturing operations, OrganaBio’s CDMO offers the cell therapy industry ready access to flexible manufacturing solutions and clinical grade cellular raw materials.
-
OrganaBio, a cell therapy CDMO, expands manufacturing with ISO 7 cleanrooms for 3rd party manufacturing and GMP cellular starting material production.
Defined Bioscience to Develop Stem Cells and iPSC-derived Tissue for Life Science and Cultivated Meat Applications
Defined Bioscience Announces Formation of Its Scientific Advisory Board
San Diego, CA, June 15, 2022 — Defined Bioscience, a life science tools company pioneering the development of next generation ingredients for cell culture, today announced the formation of its scientific advisory board (SAB). The SAB is comprised of a distinguished group of academic and industry experts who will advise the Defined Bioscience team on the development and commercialization of cell culture reagents, growth medium and kits to consistently grow high quality stem cells and iPSC-derived tissue with applications in life science and cultivated meat. [Read more…]
- « Previous Page
- 1
- …
- 29
- 30
- 31
- 32
- 33
- …
- 96
- Next Page »